Industry Bulletins | April 13, 2022
Apollo Neuro Raises $15 Million To Elevate Its Wellness Wearable To Improve Mental Health
Apollo Neuroscience, which manufactures a wearable device focused on building resilience to stress, raised $15 million in Series A funding led by Noetic Fund. The device is scalable technology to help manage stress and improve sleep. Currently the Apollo wearable is available for a one-time purchase ($349) in the United States, Canada, Europe and Australia/New Zealand. Apollo Neuro intends to use the new funding to reach new global users.
Worn on either the wrist or ankle, the Apollo device works by engaging with the sense of touch, delivering silent, soothing vibrations that help the user feel safe and . . .